Dr. Ghanta Naga Sai Snigdha, Dr. G. Ratna Kumari


   Tuberculosis (TB) is a common coinfection in Human Immunodeficiency virus (HIV) infected patients worldwide, especially in developing countries. This coinfection has dreadful social and economic impact across the globe. A decrease in CD4 T-cell counts in HIV-TB coinfection leads to increase in morbidity and mortality. This retrospective study was conducted to evaluate CD4 T-cell counts in coinfected patients of HIV and TB before and after anti tubercular treatment (ATT). Of the 186 coinfected patients observed ,160 had pulmonary tuberculosis (PTB) and 26 had extra-pulmonary tuberculosis (EPTB). The mean CD4 counts before ATT in PTB patients is 266 cells/µl and EPTB patients is 248 cells/µl and after the completion of ATT in PTB is 332 cells/µl and 397 cells/µl in EPTB patients. There was statistically significant increase in CD4 T-cell counts in both PTB and EPTB cases coinfected with HIV after ATT.


CD4 T-cell count, HIV-TB coinfection, ATT.

Full Text:



Ghiya R, Naik E, Casanas B, Izurieta R, Marfatia Y. Clinico-epidemiological profile of HIV/TB coinfected patients in Vadodara, Gujarat. Indian J Sex Transm Dis. 2009;30:10-5.

World Health Organization. Fact sheet: TB/HIV, 2020. Available at: https://www.who.int/hiv/topics/tb/about_tb/en/

Sreenivasan Srirangaraj, Dasegowda Venkatesha. Total lymphocyte count as a tool for timing opportunistic infection prophylaxis in resource limited settings: a study from India. J Infect Dev Ctries. 2010;4(10):645-9.

Niraula SR, Barnawal SP, Agrahari AK, Bista N, Yadav DK, Jha N, et al. Prevalence and CD4 cell count pattern of TB co-infection among HIV infected individuals in Nepal. SAARC J Tuber Lung Dis HIV/AIDS. 2013 ;X(1):27-36

Kavya S, Anuradha K, Venkatesha D. CD4 count evaluation in HIV-TB co infection before and after anti-tubercular treatment. Int J Res Med Sci 2014;2:1031-4.

National AIDS Control Organization. Chapter 6. Guidelines for HIV testing. In: NACO: Ministry of Health and Family Welfare. India: NACO.

Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH; Natural history of human immunodeficiency virus disease in southern India. Clin Inf Dis, 2003; 36(1): 79-85.

Lifson AR, Krantz EM, Eberly LE, Matthew Dolan J, Marconi VC, Weintrob AC; Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective Cohort. AIDS Res Ther 2011, 8(1): 2.

Swaminathan S, Narendran G. HIV and tuberculosis in India. J Biosci. 2008;33:527-37

Wanchu A, Kuttiatt VS, Sharma A, Singh S, Varma S; CD4 cell count recovery in HIV/TB co-infected patients versus TB uninfected HIV patients. Indian J Pathol Microbiol 2010; 53(4): 745-749

Onwubalili JK, Edwards AJ, Palmer L; T4 lymphopenia in human tuberculosis. Tubercle, 1987; 68(3): 195-200.

Jones BE, Oo MM, Taikwel EK, Qian D, Kumar A, Maslow ER, Barnes PF; CD4 cell counts in human immunodeficiency virus—negative patients with tuberculosis. Clinical Infectious Diseases, 1997; 24(5): 988-991

Jangid K, Shalini M, Shiwangi S, Charoo Hans;CD4 cell count recovery in HIV/TB co-infected patients in a tertiary care hospital.Sch.Acad.J.Biosci.,2015;3(6):518-521.

Elliott AM, Luzze H, Quigley MA, Nakiyingi JS, Kyaligonza S, Namujju PB, Okwera A; A Randomized, Double-Blind, Placebo-Controlled Trial of the Use of Prednisolone as an Adjunct to Treatment in HIV-1—Associated Pleural Tuberculosis. Journal of Infectious Diseases, 2004; 190(5): 869-878.

Morris L, Martin DJ, Bredell H, Nyoka SN, Sacks L, Pendle S, Chaisson RE; Human immunodeficiency virus–1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. Journal of Infectious Diseases, 2003; 187(12): 19671971.

Kalou M, Sassan M, Abouya L, Gelestin B, Chantal M, Mathieu M, et al; Change in HIV RNA viral load, CD4 T cell counts and levels and cotrimoxazole prophylaxis among HIV infected tuberculosis patients in Abidjan, Journal of Medical Virology, 2005; 75: 202-208.

Wallis RS, Vjecha M, Amir-Tahmasseb M; Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2 microglobulin in HIV-1 associated tuberculosis. J Infect Dis, 1993; 167(1): 43-48.

Lawn SD, Shattock RJ, Acheampong JW, Lal RB, Folks TM, Griffin GE, et al.; Sustained plasma TNF alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans. AIDS, 1999; 13(16): 2231-2237


  • There are currently no refbacks.